Top Global Pharma’s Consumer Business Achieves 100% Regulatory Compliance 4 Years in a Row

Ensuring compliance with regulatory submissions mandates around the world is of utmost importance for healthcare companies and failure to meet them can lead to serious consequences. Therefore, being 100% compliant is not only desired but also a great achievement for any MAH (Marketing Authorization Holder).  Regulatory requirements for reporting serious adverse events (SAEs) for devices, OTCs and cosmetics are different from that of pharma products, however, the timelines are stringent and it is still mandatory to report them.

Download this case study to learn how the company’s consumer business partnered with Sciformix to virtually eliminate late case submissions to the FDA and move the organization to achieve 100% compliance for four years in a row.